Rakuten Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.22M Buy
24,097
+2,319
+11% +$444K 0.02% 276
2026
Q1
$4.08M Buy
21,778
+2,483
+13% +$458K 0.01% 291
2025
Q4
$3.41M Sell
19,295
-179,277
-90% -$29.3M 0.01% 342
2025
Q3
$99.1M Buy
+198,572
New +$26.8M 0.35% 16
2025
Q1
$2.59M Buy
+18,708
New +$2.67M 0.01% 325
2024
Q3
$2.25M Buy
11,566
+2,917
+34% +$610K 0.01% 222
2024
Q2
$1.98M Buy
8,649
+3,270
+61% +$711K 0.01% 189
2024
Q1
$1.16M Buy
5,379
+5,021
+1,403% +$1.18M 0.01% 203
2023
Q4
$93.3K Buy
+358
New +$87.9K ﹤0.01% 198

Other funds holding BIIB

Rakuten Investment Management's BIIB Position: Q2 2026 in Review

Rakuten Investment Management increased its Biogen (BIIB) stake by 11% in Q2 2026, buying an estimated $444K and bringing the position to 24,097 shares worth $5.22M. The position accounts for 0.02% of the portfolio, ranked #276.

Rakuten Investment Management first reported a position in BIIB in Q4 2023 and has held it in 9 quarters since. The position peaked at $99.1M in Q3 2025. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Rakuten Investment Management held 24,097 shares of Biogen worth $5.22M as of Q2 2026.
  • Rakuten Investment Management bought 2,319 Biogen shares in Q2 2026, an estimated $444K.
  • Biogen made up 0.02% of Rakuten Investment Management's portfolio in Q2 2026, its #276 holding.
  • Rakuten Investment Management first reported a position in Biogen in Q4 2023 and has held it in 9 quarters since.
  • Rakuten Investment Management's Biogen position peaked at $99.1M in Q3 2025.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.